Investors Archives - Philogen Spa

Philogen is pleased to invite you to a new webinar on July 10, 2024, at 14:00 GMT | 15:00 CET.

Jul 9, 2024 | 2024, Events, Investors, Past Events

Management will provide an update on the industrial programs, including on the topline results from the Nidlegy™ Phase III trial presented at ASCO 2024. Please contact us at IR@philogen.com or follow the link register to the event.

Submission of NidlegyTM Marketing Authorization Application Validated by EMA

Jul 4, 2024 | 2024, Investors, Press Releases

For more details

Deposito del Verbale dell’Assemblea degli Azionisti

May 27, 2024 | 2024, Investors, Press Releases

more details

Philogen to attend the Goldman Sachs 45th Annual Global Healthcare Conference in Miami on June 12, 2024.

May 24, 2024 | 2024, Events, Investors

The conference provides an opportunity for investors to learn about Philogen’s progress and to meet CEO/CSO Prof. Dario Neri through a series of one-on-one meetings. Prof. Neri will give a presentation on June 12 at 1:20 pm. Follow the link here for more...

The Board of Directors approves the Net Financial Position for the First Quarter of 2024

May 7, 2024 | 2024, Investors, Press Releases

more details

Il Consiglio di Amministrazione approva la Posizione Finanziaria Netta relativa al Primo Trimestre 2024

May 7, 2024 | 2024, Investors, Press Releases

more details

Philogen is pleased to invite you to a new webinar on July 10, 2024, at 14:00 GMT | 15:00 CET.

Submission of NidlegyTM Marketing Authorization Application Validated by EMA

Deposito del Verbale dell’Assemblea degli Azionisti

Philogen to attend the Goldman Sachs 45th Annual Global Healthcare Conference in Miami on June 12, 2024.

The Board of Directors approves the Net Financial Position for the First Quarter of 2024

Il Consiglio di Amministrazione approva la Posizione Finanziaria Netta relativa al Primo Trimestre 2024

Recent Posts

Recent Comments